Rahsaan W. Thompson - 21 Jun 2026 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Reporting relationship: Chief Legal & Compliance
Issuer ticker: ZVRA
Reported as of: 21 Jun 2026
Net transaction value: -$438,304
SEC form: 4
Accepted by SEC: 23 Jun 2026, 16:16:29 UTC
Prior SEC filing: 13 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Rahsaan W. Thompson

Key filing fact

Rahsaan W. Thompson filed Form 4 for ZEVRA THERAPEUTICS, INC. (ZVRA) on 23 Jun 2026.

Key facts

This page summarizes Rahsaan W. Thompson's Form 4 filing for ZEVRA THERAPEUTICS, INC. (ZVRA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Jun 2026, 16:16.

Change

Previous filing in this sequence was filed on 13 May 2026.
Current net transaction value: -$438,304.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001788524 Primary reporting owner

Thompson Rahsaan

Relationship: Chief Legal & Compliance
Address: C/O ZEVRA THERAPEUTICS, INC., 101 FEDERAL STREET, BOSTON
Signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Rahsaan W. Thompson
Signature date: 23 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZVRA transaction

Common Stock

Options Exercise

Transaction value
Shares: +66,667
Change %: +139%
Price
Shares after: 114,792
Date: 21 Jun 2026
Ownership: Direct
Footnotes: F1

ZVRA transaction

Common Stock

Sale

Transaction value: $438,304
Shares: -34,557
Change %: -30%
Price: $12.68
Shares after: 80,235
Date: 22 Jun 2026
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZVRA transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -66,667
Change %: -50%
Price: $0.000000^*
Shares after: 66,667
Date: 21 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 66,667
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

Adoption date of referenced 10b5-1(c) plan is: 01-08-2026.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $12.53 to $13.19. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

The first and second tranches of the restricted stock units vested and settled on June 21, 2025 and June 21, 2026, respectively, and the remaining tranche of the restricted stock units will vest and settle on the next anniversary thereafter, subject to the Reporting person's continued service through such vesting date.